Cancer vaccines based on HSP-peptide complexes are promising because molecular chaperones, such as HSP70 and HSP90, have been shown to form complexes with a wide panel of peptides, including antigenic peptides [81,82]. This evidence concerns the gene HSP90B2P and cancer.